Testing effectiveness (Phase 2)Study completedNCT00003683What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT01220973What this trial is testingAtorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerWho this might be right forProstate Cancer Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)UnknownNCT01131429What this trial is testingA Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsWho this might be right forNeoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01004731What this trial is testingStudy of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerWho this might be right forStage IV Non-Small Cell Lung Cancer University of Alabama at Birmingham 7
Testing effectiveness (Phase 2)Study completedNCT03800602What this trial is testingNivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerWho this might be right forColorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaRefractory Colorectal Carcinoma+5 more Emory University 29
Testing effectiveness (Phase 2)Study completedNCT00054145What this trial is testingPerifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerWho this might be right forBreast Cancer University Health Network, Toronto
Testing effectiveness (Phase 2)UnknownNCT00838656What this trial is testingTwo Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Warwick Medical School 88
Early research (Phase 1)Study completedNCT02858869What this trial is testingPembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more Emory University 25
Testing effectiveness (Phase 2)Study completedNCT00005873What this trial is testingNitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00311545What this trial is testingS0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT05319639What this trial is testingPhase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabWho this might be right forGastric Cancer Stage IV Fujian Cancer Hospital 51
Testing effectiveness (Phase 2)UnknownNCT00005877What this trial is testingNitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal CancerWho this might be right forColorectal Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00671554What this trial is testingTrial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant MelanomaWho this might be right forMelanoma Prisma Health-Upstate 3
Not applicableLooking for participantsNCT07776353What this trial is testingUnderstanding New Cachexia Subtypes Through Observational Epidemiological ResearchWho this might be right forAdvanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Pancreatic Adenocarcinoma+5 more Kaiser Permanente 800
Early research (Phase 1)Ended earlyNCT05274451What this trial is testingInvestigate LYL797 in Adults With Solid TumorsWho this might be right forTriple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more Lyell Immunopharma, Inc. 57
Large-scale testing (Phase 3)Ended earlyNCT00920153What this trial is testingThree Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin LymphomaWho this might be right forLymphoma French Innovative Leukemia Organisation 442
Testing effectiveness (Phase 2)Ended earlyNCT00301795What this trial is testingRituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forStage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+3 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT01624441What this trial is testingDinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+4 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT02575794What this trial is testingTerameprocol in Treating Patients With Recurrent High Grade GliomaWho this might be right forHigh Grade Glioma (III or IV) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35